Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NTSR2 | O95665 | 17/20 | 0.49 |
| ▸ | NTSR1 | P30989 | 17/20 | 0.49 |
| ▸ | SORT1 | Q99523 | 15/20 | 0.49 |
| ▸ | CAPN1 | P07384 | 2/20 | 0.49 |
| ▸ | REN | P00797 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29664292 | 0.89 | XIAP (0.50) | NTSR2NTSR1SORT1CAPN1REN | |
| SCHEMBL29614726 | 0.88 | NTSR2 (0.51) | NTSR2NTSR1SORT1CAPN1 | |
| SCHEMBL31409133 | 0.86 | CAPN1 (0.53) | NTSR2NTSR1SORT1CAPN1 | |
| Davunetide SCHEMBL19712227 | 0.85 | XIAP (0.48) | NTSR2NTSR1SORT1 | |
| Davunetide SCHEMBL239736 | 0.85 | XIAP (0.48) | NTSR2NTSR1SORT1 | |
| Davunetide SCHEMBL3689039 | 0.85 | XIAP (0.48) | NTSR2NTSR1SORT1 | |
| Davunetide SCHEMBL239737 | 0.85 | XIAP (0.48) | NTSR2NTSR1SORT1 | |
| SCHEMBL30777830 | 0.85 | XIAP (0.48) | NTSR2NTSR1SORT1CAPN1 | |
| SCHEMBL29678075 | 0.84 | MAPK8 (0.47) | NTSR2NTSR1SORT1CAPN1REN | |
| SCHEMBL13035034 | 0.84 | XIAP (0.47) | NTSR2NTSR1SORT1REN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12618102-B2 | Biochemical reaction methods and reagents comprising intrinsically disordered regions | Biocrucible Limited (GB) | 2026-05-05 | — | — | US | disclosed |
| US-20220112547-A1 | BIOCHEMICAL REACTION METHODS AND REAGENTS COMPRISING INTRINSICALLY DISORDERED REGIONS | Biocrucible Limited (GB) | 2022-04-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12618102-B2 | Biochemical reaction methods and reagents comprising intrinsically disordered regions | POLM, POLR1A, POLR1E | NTSR2 3599/4885NTSR1 2903/4885SORT1 3118/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.